Ozempic (Semaglutide) 10 Injections

Ozempic (Semaglutide) Injection
Product Description
Ozempic (semaglutide) is a prescription GLP-1 receptor agonist indicated for the management of type 2 diabetes mellitus in adults, as an adjunct to diet and exercise. It helps lower blood sugar levels and can also support weight management in appropriate patients. Semaglutide works by enhancing insulin secretion, slowing gastric emptying, and reducing appetite.
Composition & Format
Active ingredient: Semaglutide 1.34 mg/ml 
Available as multi-dose injection vials
Benefits
Improves blood glucose control in adults with type 2 diabetes
Reduces risk of major cardiovascular events in patients with type 2 diabetes and established heart disease
Promotes weight reduction by decreasing appetite and slowing digestion
May improve insulin sensitivity and support long-term metabolic health
Dosage & Administration
Route: Subcutaneous (under the skin), not intramuscular
Typical dosing schedule (for type 2 diabetes, per prescribing information):
Start: 0.25 mg once weekly for 4 weeks (for initiation, not for glycemic control)
Increase to 0.5 mg once weekly
Dose may be increased to 1 mg once weekly, and in some cases up to 2 mg once weekly, as directed by a healthcare provider
Storage
Refrigerate at 2°C to 8°C (36°F to 46°F)
Do not freeze. Protect from direct heat and light. Keep cap on when not in use.
Notes
Ozempic is intended for patients with type 2 diabetes; it is not approved for type 1 diabetes or diabetic ketoacidosis.
Should be prescribed and monitored by a healthcare provider.
Common side effects: nausea, vomiting, diarrhea, constipation, and abdominal pain.
Serious risks may include pancreatitis, thyroid C-cell tumors, and gallbladder issues—patients should be screened and monitored accordingly.